Found: 10
Select item for more details and to access through your institution.
A Phase IV Study of the Safety and Efficacy of CinnoPar<sup>®</sup> in Iranian Patients with Osteoporosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Evaluating the safety and effectiveness of PegaGen<sup>®</sup> (pegfilgrastim) for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 10, p. 8151, doi. 10.1007/s00520-022-07265-2
- By:
- Publication type:
- Article
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.682622
- By:
- Publication type:
- Article
Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67945-3
- By:
- Publication type:
- Article
Comparison of Two Treatment Strategies in Inflammatory Bowel Disease: Biosimilar Adalimumab Monotherapy or in Combination with Azathioprine.
- Published in:
- Iranian Journal of Gastroenterology & Hepatology (GOVARESH), 2023, v. 27, n. 4, p. 220
- By:
- Publication type:
- Article
Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study.
- Published in:
- Archives of Iranian Medicine (AIM), 2023, v. 26, n. 11, p. 647, doi. 10.34172/aim.2023.95
- By:
- Publication type:
- Article
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS‐CoV‐2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo‐controlled trial.
- Published in:
- Immunology, 2022, v. 167, n. 3, p. 340, doi. 10.1111/imm.13540
- By:
- Publication type:
- Article
Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study.
- Published in:
- Caspian Journal of Internal Medicine, 2021, p. S491, doi. 10.22088/cjim.12.0.491
- By:
- Publication type:
- Article
Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia®) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02840-8
- By:
- Publication type:
- Article